About this trial
This is an interventional neuroimaging study that will examine whether fMRI neurofeedback can shift language network activity away from regions affected by glioma prior to surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Diagnosis of WHO grade II-III glioma involving eloquent language cortex
Scheduled for surgical resection
Disqualifiers
Severe baseline aphasia precluding task performance
Contraindications to MRI
Significant cognitive/psychiatric comorbidity limiting compliance
Concurrent enrollment in other interventional trials
Trial design
Single group
Treatments tested in this trial
fMRI
DeviceReal-time functional magnetic resonance imaging (fMRI) neurofeedback (NF)
Treatment groups
Trial outcomes
Primary outcomes
Number of participants enrolled to assess feasibility
Number of participants enrolled out of all screened
Number of participants completing all study visits to assess feasibility
Number of participants completing all study visits within the standard presurgical window
Number of device-related adverse events to assess safety
Number of device-related adverse events
Mean score Patient Experience Questionnaire (PEQ) to assess acceptability
Participant-reported acceptability and perceived burden as measured by the Patient Experience Questionnaire (PEQ). Total score range 1-5 with higher scores indicating better experiences.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.